Yokohama, Japan

Akiko Koganei

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Toyo Seikan Group Holdings, Ltd.. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akiko Koganei. Retrieved from https://idiyas.com/inventor/akiko-koganei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.8

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Akiko Koganei: Innovator in Antiviral Solutions

Introduction

Akiko Koganei is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of antiviral solutions, holding a total of 3 patents. Her innovative work focuses on the development of dispersion solutions that exhibit antiviral properties.

Latest Patents

One of her latest patents is a dispersion solution having antiviral properties. This solution includes a solvent containing fine particles of a copper compound, a stabilizer, a fatty acid, a fatty acid ester, and a polycarboxylic acid. The fine particles of the copper compound are homogeneously dispersed in the medium, maintaining stability over extended periods. Another notable patent involves metallic copper fine particles coated with a fatty acid and an ester compound. This patent also discloses an antiviral agent containing these metallic copper fine particles and a method for their production.

Career Highlights

Akiko Koganei is associated with Toyo Seikan Group Holdings, Ltd., where she continues to innovate and contribute to the field of antiviral research. Her work has garnered attention for its potential applications in health and safety.

Collaborations

She collaborates with notable colleagues, including Kazuaki Ohashi and Yasuhiro Kosaka, who contribute to her research endeavors.

Conclusion

Akiko Koganei's innovative work in antiviral solutions showcases her dedication to advancing health technologies. Her patents reflect her commitment to creating effective solutions for public health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…